GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

NCT03943875 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

767

Enrollment

OTHER

Sponsor class

Conditions

Immunization
Efficacy
Human Papilloma Virus

Interventions

BIOLOGICAL: 9-valent HPV vaccine, 2 dose efficacy
BIOLOGICAL: 9-valent HPV vaccine, 3 doses standard timing

Sponsor

The University of Texas Medical Branch, Galveston

Collaborators

[object Object]